The natural organosulfur compound dipropyltetrasulfide prevents HOCl-induced systemic sclerosis in the mouse

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Marut, Wioleta ^a   Jamier, Vincent ^a,b   Kavian, Niloufar ^a   Servettaz, Amélie ^a,c   Winyard, Paul G ^c   Eggleton, Paul ^d   Anwar, Awais ^e   Nicco, Carole ^a   Jacob, Claus ^b   Chéreau, Christiane ^a   Weill, Bernard ^a   Batteux, Frédéric ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAARLAND UNIVERSITY   (Germany)

^c SERVICE DE DERMATOLOGIE   (France)

^d UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^e ECOSPRAY LIMITED   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; COLLAGEN; DIPROPYLTETRASULFIDE; DNA TOPOISOMERASE; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; INTERLEUKIN 13; INTERLEUKIN 4; ORGANOSULFUR DERIVATIVE; UNCLASSIFIED DRUG; ACTIN; AUTOANTIBODY; DIPROPYL TETRASULFIDE; SMAD PROTEIN; SULFIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; EX VIVO STUDY; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN; SKIN FIBROBLAST; SPLEEN CELL; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; FIBROSIS; FLOW CYTOMETRY; IMMUNOLOGY; LUNG; LYMPHOCYTE; METABOLISM; PATHOLOGY; SKIN;

ACTINS; ANIMALS; APOPTOSIS; AUTOANTIBODIES; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DNA TOPOISOMERASES, TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLASTS; FIBROSIS; FLOW CYTOMETRY; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; INTERLEUKIN-13; INTERLEUKIN-4; LUNG; LYMPHOCYTES; MICE; MICE, INBRED BALB C; SCLERODERMA, SYSTEMIC; SKIN; SMAD PROTEINS; SULFIDES;

EID: 84887951520     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4351     Document Type: Article

References (23)

1. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
2. Simonini G, Cerinic MM, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M. Oxidative stress in systemic ssclerosis. Mol Cell Biochem 1999, 196:85-91. 10.1023/A:1006922313774, 10448906.
3. Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, Gabrielli A. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001, 44:2653-2664. 10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1, 11710721.
4. Lafyatis R, York M. Innate immunity and inflammation in systemic sclerosis. Curr Opin Rheumatol 2009, 21:617-622. 10.1097/BOR.0b013e32832fd69e, 2848972, 19633559.
5. Sato S, Fujimoto M, Hasegawa M, Takehara K. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 2004, 50:1918-1927. 10.1002/art.20274, 15188368.
6. Marut WK, Kavian N, Servettaz A, Nicco C, Ba LA, Doering M, Chereau C, Jacob C, Weill B, Batteux F. The organotelluride catalyst (PHTE)(2)NQ prevents HOCl-induced systemic sclerosis in mouse. J Invest Dermatol 2012, 132:1125-1132. 10.1038/jid.2011.455, 22277946.
7. Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chereau C, Vuiblet V, Guillevin L, Mouthon L, Weill B, et al. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 2009, 182:5855-5864. 10.4049/jimmunol.0803705, 19380834.
8. Groschel B, Bushman F. Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus. J Virol 2005, 79:5695-5704. 10.1128/JVI.79.9.5695-5704.2005, 1082730, 15827184.
9. Kelkel M, Cerella C, Mack F, Schneider T, Jacob C, Schumacher M, Dicato M, Diederich M. ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis. Carcinogenesis 2012, 33:2162-2171. 10.1093/carcin/bgs240, 22822094.
10. Busch C, Jacob C, Anwar A, Burkholz T, Aicha Ba L, Cerella C, Diederich M, Brandt W, Wessjohann L, Montenarh M. Diallylpolysulfides induce growth arrest and apoptosis. Int J Oncol 2010, 36:743-749.
11. Lawson LD, Wang ZJ, Hughes BG. Identification and HPLC quantitation of the sulfides and dialk(en)yl thiosulfinates in commercial garlic products. Planta Med 1991, 57:363-370. 10.1055/s-2006-960119, 1775579.
12. Alexandre J, Nicco C, Chereau C, Laurent A, Weill B, Goldwasser F, Batteux F. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 2006, 98:236-244. 10.1093/jnci/djj049, 16478742.
13. Burdick MD, Murray LA, Keane MP, Xue YY, Zisman DA, Belperio JA, Strieter RM. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am J Respir Crit Care Med 2005, 171:261-268. 10.1164/rccm.200409-1164OC, 15502109.
14. Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy MC, Kwon JJ, Keane MP, Strieter RM. CXCR2 is critical to hyperoxia-induced lung injury. J Immunol 2004, 172:3860-3868.
15. Kavian N, Marut W, Servettaz A, Nicco C, Chereau C, Lemarechal H, Borderie D, Dupin N, Weill B, Batteux F. Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis. Arthritis Rheum 2012, 64:3430-3440. 10.1002/art.34534, 22576901.
16. Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J Clin Invest 2004, 113:253-264. 310747, 14722617.
17. Li WQ, Qureshi HY, Liacini A, Dehnade F, Zafarullah M. Transforming growth factor beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species. Free Radic Biol Med 2004, 37:196-207. 10.1016/j.freeradbiomed.2004.04.028, 15203191.
18. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 1992, 35:67-72. 10.1002/art.1780350111, 1731816.
19. Lau BH, Yamasaki T, Gridley DS. Garlic compounds modulate macrophage and T-lymphocyte functions. Mol Biother 1991, 3:103-107. 10.1007/BF02172082, 1910619.
20. Nakamura Y, Miyoshi N. Cell death induction by isothiocyanates and their underlying molecular mechanisms. Biofactors 2006, 26:123-134. 10.1002/biof.5520260203, 16823098.
21. Zhang G, Wu H, Zhu B, Shimoishi Y, Nakamura Y, Murata Y. Effect of dimethyl sulfides on the induction of apoptosis in human leukemia Jurkat cells and HL-60 cells. Biosci Biotechnol Biochem 2008, 72:2966-2972. 10.1271/bbb.80453, 18997406.
22. Kavian N, Marut W, Servettaz A, Laude H, Nicco C, Chereau C, Weill B, Batteux F. Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease. J Immunol 2012, 188:5142-5149. 10.4049/jimmunol.1103538, 22491256.
23. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 1997, 24:328-332.